Association between Chronic Psychological Stress, Cortisol Dysregulation, and Risk of Breast Cancer Development in Women. A Case Control Clinical Study
DOI:
https://doi.org/10.53350/pjmhs020251911.4Keywords:
breast cancer, stress, cortisol, HPA axis, women, psychological stress.Abstract
Background: Chronic psychological stress has been seen as a more and more probable factor in the development of cancer via its impact on the hypothalamic-pituitary-adrenal (HPA) axis and dysregulation of cortisol. Nevertheless, there is limited evidence among clinical populations (especially in low- and middle-income nations).
Objectives: To assess the relationship between chronic psychological stress and cortisol dysregulation and the risk of breast cancer in women.
Methods: The present study is a hospital-based case-control study, comprising of 47 women with a newly diagnosed, histologically confirmed breast cancer and 47 age-matched healthy women, as controls. A structured proforma was used to record the sociodemographic variables, reproductive history and exposure to chronic stress. The Perceived Stress Scale (PSS-10) was used to measure psychological stress. Cortisol levels in the morning went through tests of chemiluminescent immunoassay and evening cortisol in a subset was taken to determine the diurnal rhythm. Dysregulation of cortisol was characterized by abnormal morning cortisol and/or flattened morning to evening cortisol ratio. The statistical tests were chi-square, independent t-test and multivariate logistic regression.
Results: PSS scores were much higher among breast cancer patients than they were among controls (24.8 vs. 17.2, p < 0.001). The cases were much more likely to have high psychological stress and long-term stressors in life. The mean morning cortisol levels were greater in cases (19.6 3g/dl) compared to controls (14.2 3g/dl) and cortisol dysregulation was more common in cases (61.7 vs. 27.6, p < 0.001). Multivariable regression demonstrated stress (AOR: 3.84) and dysregulated cortisol (AOR: 4.46) to be high predictors of breast cancer.
Conclusion: Cryptic psychological stress and dysregulation of cortisol are both of significant relevance in risking breast cancer. The stress and endocrine imbalance screening can be used to detect women who are at high risks and aid the preventive measures.
References
Antoni MH, Lutgendorf SK. Psychosocial influences on cancer progression. Nat Rev Cancer. 2017;17(12):766-82. doi:10.1038/nrc.2017.82
Reiche EM, Nunes SO, Morimoto HK. Stress and cancer: the biological interface. Clin Sci. 2016;130(12):1041-57. doi:10.1042/CS20160036
Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence? Nat Clin Pract Oncol. 2018;6(8):466-75. doi:10.1038/ncponc1134
Fang Y, Zhang L, Li Z. Chronic stress and cancer risk: molecular mechanisms. Cancer Lett. 2019;459:203-11. doi:10.1016/j.canlet.2019.05.036
Slavich GM. Psychoneuroimmunology of stress and cancer. Psychology. 2020;71(4):237-48. doi:10.1037/bul0000219
Morita T, Kimura M, Yoshida S. Psychological stress and breast cancer incidence. Breast Cancer Res Treat. 2016;158(1):67-75. doi:10.1007/s10549-015-3848-4
Zhang J, Zheng Y. Cortisol rhythm and cancer risk. Endocr Connect. 2017;6(7):R108-R118. doi:10.1530/EC-17-0093
Marchetti GM, Monaco A, Cattaneo E. Stress biomarkers and breast cancer risk. J Psychosom Res. 2019;125:109814. doi:10.1016/j.jpsychores.2019.109814
Sephton SE, Dhabhar FS. Stress physiology and breast tumor progression. Brain Behav Immun. 2017;64:260-70. doi:10.1016/j.bbi.2017.04.015
Lamkin DM, Sloan EK. Chronic stress, inflammation, and cancer. Brain Behav Immun. 2020;83:1-6. doi:10.1016/j.bbi.2019.09.015
Qi Y, Li F, Wang J. Stress exposure and breast cancer risk in women. Int J Clin Oncol. 2018;23(6):1120-1128. doi:10.1007/s10147-018-1292-2
Habib S, Raza S, Hassan M. Psychosocial stress and cancer risk in South Asian women. J Pak Med Assoc. 2019;69(10):1474-1479.
Li X, Wang K, Chen H. Diurnal cortisol patterns and hormone-dependent cancers. Steroids. 2017;118:12-18. doi:10.1016/j.steroids.2016.12.006
Wu X, Li J, Xu L. Cortisol dysregulation in malignancy. Endocr Relat Cancer. 2019;26(2):R105-R114. doi:10.1530/ERC-18-0304
Baqai H, Fatima N, Khan MN. Stress indicators and breast cancer correlation. Asian Pac J Cancer Prev. 2018;19(9):2471-2476. doi:10.22034/APJCP.2018.19.9.2471
Ibrahim M, Khan T, Ali S. Psychoneuroendocrine pathways in cancer risk. Curr Oncol. 2020;27(4):214-220. doi:10.3747/co.27.6230
Collier JK, Garcia D, Bower JE. Stress-related cortisol changes and tumor biology. Psychooncology. 2019;28(10):2044-2053. doi:10.1002/pon.5195
Darbandi M, Mirzaei H, Khosravi A. Stress hormones and DNA damage in breast cancer. Mol Biol Rep. 2021;48(3):2561-2569. doi:10.1007/s11033-021-06231-z
Ahmed F, Jamil S, Rafiq N. Endocrine stress markers and breast tumorigenesis in Pakistani women. Pak J Med Sci. 2022;38(1):182-188. doi:10.12669/pjms.38.1.4527
Li T, Zhao H, Zhou L. Neuroendocrine imbalance and female cancers. J Endocrinol Invest. 2020;43(5):563-572. doi:10.1007/s40618-019-01155-
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 MUHAMMAD HAMZA, USAMA NAEEM, SAMEEN ATHAR, HAMNAA AFZAL, AYESHA FATIMA NIAZI, JAVERIA ASLAM, MUHAMMAD UMAR ABBAS, AIMEN ABBAS
This work is licensed under a Creative Commons Attribution 4.0 International License.
